A Prospective, Multicenter, Open-Label Study to Evaluate the Safety and Efficacy of a Cream Containing Xyloglucan, Pea Protein, and Opuntia Ficus-Indica Extract Versus Calcipotriol/Betamethasone in Adult Patients with Mild-to-Moderate Psoriasis.
March 2024
in “
PubMed
”
TLDR The cream with xyloglucan, pea protein, and cactus extract works as well as the standard treatment for psoriasis and is well-tolerated.
The study compared the efficacy and safety of a cream containing xyloglucan, pea protein, and Opuntia ficus-indica extract (XPO) to calcipotriol/betamethasone (CB) in adult patients with mild-to-moderate psoriasis. XPO demonstrated similar efficacy to CB in significantly reducing disease severity, erythema, itching, induration, and scaling. Additionally, XPO exhibited an excellent tolerability profile, suggesting it is a viable alternative treatment option for psoriasis.
